Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib vs Herceptin in HER2-positive Breast Cancer
NCT03085368Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lapatinib in breast cancer, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03085368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085368.